NMPA accepts clinical trial application for monkeypox vaccine
chinadaily.com.cn |
Updated: 2023-07-14 19:44
Share
Share - WeChat
The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.
- Police rescue 3-year-old hanging from 7th-floor window
- China sees steady passenger trip increase in 2024
- China signs global pact to explore space weather
- Zhangye's desert oasis dazzles in early summer
- Coastal areas prepare for year's first typhoon
- Remains of former senior Chinese legislator Ragdi cremated
